PARIS Sanofi's most senior strategy boss is set to leave by the end of the month, according to a memo seen by Reuters, in the first major management change under new chief executive Paul Hudson as he shakes up the firm's priorities.
FRANKFURT/PARIS Sanofi is considering a joint venture or outright sale among options for its consumer healthcare unit, sources told Reuters, as the French drugmaker prepares to present a new strategic plan next month.
PARIS Sanofi expressed confidence for the fourth quarter and confirmed its full-year objectives on Thursday after posting lower third-quarter sales, hit by a fall in revenue at its primary care and vaccines businesses.
PARIS A landmark French trial will from next week seek to settle one of the country's biggest pharmaceutical scandals, probing whether the company behind a weight-loss drug believed to have triggered killer side-effects covered up the risks.
PARIS, Sept 13 Parisian commuters faced travel
chaos on Friday as transport workers went on strike over plans
to reduce their retirement privileges in a challenge to
President Emmanuel Macron's pension reform plans.
PARIS EssilorLuxottica is buying Dutch opticians group GrandVision for up to 7.2 billion euros ($8 billion) in cash to take control of thousands of stores where it sells spectacles and lenses.
PARIS Sanofi has raised its 2019 outlook on the back of strong second-quarter results, which benefited from double-digit growth at the French drugmaker's vaccines and rare diseases businesses.
PARIS Laboratory-testing company Eurofins Scientific plans to slow its frantic dealmaking pace in the next two years while also expanding in emerging markets to maintain double-digit sales growth over the next decade, its finance director said.